Department of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Section of Urologic Oncology Surgery, Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
BJU Int. 2021 Sep;128(3):304-310. doi: 10.1111/bju.15329. Epub 2021 Jan 20.
To investigate the prevalence of catheterisation and urinary retention in male patients with bladder cancer after radical cystectomy (RC) and orthotopic neobladder (ONB) and to identify potential predictors.
Using an Institutional Review Board approved, prospectively maintained bladder cancer database, we collected information using a diversion-related questionnaire from 299 consecutive male patients with bladder cancer upon postoperative clinic visit. Urinary retention was defined as ≥3 catheterisations/day or a self-reported inability to void without a catheter. Uni- and multivariable Cox regression analysis was performed to identify predictors of catheterisation and urinary retention.
Self-catheterisation was reported in 51 patients (17%), of whom, 22 (7.4% of the total patients) were in retention. Freedom from any catheterisation at 3, 5, and 10 years after RC was 85%, 77%, and 62%, respectively. Freedom from retention at 3, 5, and 10 years after RC was 93%, 88%, and 79%, respectively. Multivariable Cox regression showed that higher body mass index (BMI; ≥27 kg/m ) significantly increased the need for catheterisation (hazard ratio [HR] 2.34, 95% confidence interval [CI] 1.26-4.32) as well as retention (HR 5.20, 95% CI 1.74-15.51). Greater medical comorbidity (Charlson Comorbidity Index score ≥2) correlated with the need for any catheterisation (HR 1.84, 95% CI 1.02-3.3), but not retention. Pathological stage and type of diversion were not significant predictors of the need to catheterise or urinary retention.
In males undergoing RC with ONB, retention requiring catheterisation to void is uncommon. Patients with a BMI of ≥27 kg/m are at significantly increased risk of retention and need for self-catheterisation.
调查根治性膀胱切除术(RC)和原位新膀胱(ONB)后男性膀胱癌患者置管和尿潴留的发生率,并确定潜在的预测因素。
我们使用经机构审查委员会批准的前瞻性膀胱肿瘤数据库,通过与分流术相关的问卷调查,收集 299 例连续男性膀胱癌患者术后就诊时的信息。尿潴留定义为≥3 次/天的置管或自述不能在无导尿管的情况下排尿。采用单变量和多变量 Cox 回归分析来识别置管和尿潴留的预测因素。
51 例(17%)患者报告自行置管,其中 22 例(总患者的 7.4%)存在尿潴留。RC 后 3、5 和 10 年无任何置管的患者比例分别为 85%、77%和 62%。RC 后 3、5 和 10 年无尿潴留的患者比例分别为 93%、88%和 79%。多变量 Cox 回归显示,较高的体质指数(BMI;≥27kg/m )显著增加了置管的需求(风险比[HR] 2.34,95%置信区间[CI] 1.26-4.32)和尿潴留(HR 5.20,95% CI 1.74-15.51)。更高的医疗合并症(Charlson 合并症指数评分≥2)与任何置管的需求相关(HR 1.84,95% CI 1.02-3.3),但与尿潴留无关。病理分期和分流类型不是置管或尿潴留的显著预测因素。
在接受 RC 联合 ONB 的男性患者中,需要导尿才能排尿的尿潴留并不常见。BMI 为≥27kg/m 的患者发生潴留和需要自行置管的风险显著增加。